Raabe et al. [16] suggest that PHOX2B up-regulation is simply a marker of tumour lineage and not a contributor to malignant phenotype, given that neuroblastoma arise at a time when PHOX2B is normally expressed during neurodevelopment, and its forced overexpression decreases proliferation. This evidence concerns the gene PHOX2B and neoplasm.